Skip to content
Chairman & CEO, Xontogeny
Head, Corporate Affairs, Alexion/AstraZeneca Rare Disease
Immediate Past Chair
Immediate Past Chair, MassBio
President & CEO, Anika Therapeutics, Inc.
President & Chief Business Officer, RareStone Inc.
President & CEO, Theseus Pharmaceuticals
President & CEO, Genocea Biosciencs, Inc.
Vice President, Discovery Biotherapeutics, East Coast, Bristol Myers Squibb
Managing Director, Life Sciences, JLL
Head of Research & Development, Neumora
Executive Director, Scientific Affairs & External Partnership and Kendall Square Site Lead, Pfizer
Vice President, Global Public Policy & Government Relations, Alnylam Pharmaceuticals
President & CEO, Organogenesis Inc.
Principal, RMG Associates
Managing Partner, Dana-Farber Cancer Institute, Binney Street Capital; CEO
Chief Science Officer, Danaher Corporation
Chief Marketing Officer, Andreessen Horowitz (a16z) Bio+Health
Chief Investment Officer, AMR Action Fund
SVP, Value and Access, Biogen
Vice President and Head, BD&L Boston & European Innovation Hubs, Merck & Co., Inc.
Head of Global Oncology Patient Value, Policy and Access, Takeda
Managing Director, American Cancer Society’s BrightEdge Fund
Co-founder, President & CEO, Frequency Therapeutics
Chair, President & CEO, Rhythm Pharmaceuticals
President & CEO, Editas Medicine
Partner, McDermott, Quilty & Miller LLP
Head, Roche Molecular Labs
Chair & CEO, Infinity Pharmaceuticals
Head, Johnson & Johnson Innovation, East North America
Global Head, Innovation Hubs, Danaher
Vice President, Government Relations & Public Affairs, Sunovion
Executive VP, CPO, COS, Vertex
Executive Vice President & Head, Sanofi Genzyme
Executive Vice President & CBO, Turning Point Therapeutics
Chief Regulatory Officer, Nuvation Bio